Trials in neuropathic diabetic foot ulceration: Time for a paradigm shift?

Diabetes Care

Volumn 26, Issue 9, 2003, Pages 2689-2690

  Boulton, Andrew J M ^a,b   Armstrong, David G ^b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; VASCULOTROPIN;

ANGIOGENESIS; ANTIBIOTIC THERAPY; BANDAGE; CLINICAL TRIAL; COST MINIMIZATION ANALYSIS; DEVICE; DIABETIC FOOT; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; FOOT AMPUTATION; FOOT ULCER; HUMAN; LIMB ISCHEMIA; LIMB PROSTHESIS; MORBIDITY; OUTCOMES RESEARCH; PLASTER CAST; SENSORY NEUROPATHY; ULCER HEALING; WALKING AID; WOUND INFECTION;

CLINICAL TRIALS; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; HUMANS; MODELS, BIOLOGICAL;

EID: 0041823195     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.9.2689     Document Type: Editorial

References (13)

1. Mayfiel JA, Reiber GE, Sanders LJ, Janise D, Pogach LM: Preventive foot care in people with diabetes. Diabetes Care 21:2161-2177, 1998
2. Mason J, O'Keeffe C, Hutchinson A, McIntosh A, Young RJ, Booth A: A systematic review of foot ulcers in patients with type 2 diabetes mellitus. II: treatment. Diabet Med 16:889-909, 1999
3. Kalani M, Apelqvist J, Blombäck M, Brismar K, Eliasson B, Eriksson JW, Fagrell B, Hamsten A, Torffvit O, Jörneskog G: Effect of dalteparin on healing chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care 26:2575-2580, 2003
4. Manninen HI, Makinen K: Gene therapy techniques for peripheral arterial disease. Carciovasc Intervent Radiol 25:98-108, 2002
5. Kusumanto YH, Hospers GA, Mulder NH, Tio RA: Therapeutic angiogenesis with vascular endothelia growth factor in peripheral and coronary artery disease: a review. Int J Cardiovasc Intervent 5:27-34, 2003
6. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJM: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22:157-162, 1999
7. Jude EB, Boulton AJM: End-stage complications of diabetic neuropathy. Diab Rev 7:395-410, 1999
8. Knowles EA, Boulton AJM: Do people with diabetes wear their prescribed footwear? Diabet Med 13:1064-1068, 1996
9. Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJM: Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 26:2595-2597, 2003
10. Armstrong DG, Nguyen HC, Lavery LA, van Schie CHM, Boulton AJM, Harkless LB: Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 24:1019-1022, 2001
11. Lavery LA, Vela SA, Lavery DC, Quebedeaux TL: Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulceration: a comparison of treatments. Diabetes Care 19:818-821, 1996
12. Veves A, Sheehan P, Pham HT: A randomized controlled trial of promogran vs standard treatment in the management in the management of diabetic foot ulcers. Arch Surg 137:822-827, 2002
13. Armstrong DG, Short B, Espensen EH, Abu-Rumman PL, Nixon BP, Boutton AJM: Technique for fabrication of an instant total-contact cast for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc 92:405-408, 2002